These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10566619)

  • 1. Intratumoral angiogenesis: a new prognostic indicator for stage I endometrial adenocarcinomas?
    Giatromanolaki A; Sivridis E; Koukourakis MI; Georgoulias V; Gatter KC; Harris AL
    Oncol Res; 1999; 11(4):205-12. PubMed ID: 10566619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis, p53, and bcl-2 expression as prognostic indicators in endometrial cancer: comparison with traditional clinicopathologic variables.
    Erdem O; Erdem M; Dursun A; Akyol G; Erdem A
    Int J Gynecol Pathol; 2003 Jul; 22(3):254-60. PubMed ID: 12819392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
    Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
    Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
    Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
    Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
    Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis and Bcl-2 protein expression in patients with endometrial carcinoma.
    Mazurek A; Pierzynski P; Niklinska W; Chyczewski L; Laudanski T
    Neoplasma; 2002; 49(3):149-54. PubMed ID: 12097999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature.
    Kounelis S; Kapranos N; Kouri E; Coppola D; Papadaki H; Jones MW
    Mod Pathol; 2000 Apr; 13(4):379-88. PubMed ID: 10786803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
    Fine BA; Valente PT; Feinstein GI; Dey T
    Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of tumor angiogenesis and thymidine phosphorylase tissue expression in patients with endometrial cancer.
    Mazurek A; Kuc P; Terlikowski S; Laudanski T
    Neoplasma; 2006; 53(3):242-6. PubMed ID: 16652195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myometrial invasion and lymph node metastasis in endometrioid carcinomas: tumor-associated macrophages, microvessel density, and HIF1A have a crucial role.
    Espinosa I; José Carnicer M; Catasus L; Canet B; D'angelo E; Zannoni GF; Prat J
    Am J Surg Pathol; 2010 Nov; 34(11):1708-14. PubMed ID: 20962622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The relationship between angiogenesis and p53 overexpression in endometrioid adenocarcinoma].
    Yao Y; Peng Z; Yin R
    Zhonghua Fu Chan Ke Za Zhi; 1999 Nov; 34(11):667-9. PubMed ID: 11479949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenic co-operation of VEGF and stromal cell TP in endometrial carcinomas.
    Sivridis E; Giatromanolaki A; Anastasiadis P; Georgiou L; Gatter KC; Harris AL; Bicknell R; Koukourakis MI;
    J Pathol; 2002 Apr; 196(4):416-22. PubMed ID: 11920737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of bcl-2 persistence: an independent prognostic indicator of poor prognosis in endometrial carcinoma.
    Geisler JP; Geisler HE; Wiemann MC; Zhou Z; Miller GA; Crabtree W
    Gynecol Oncol; 1998 Nov; 71(2):305-7. PubMed ID: 9826476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-2 and p53 expression in stage I endometrial carcinoma.
    Giatromanolaki A; Sivridis E; Koukourakis MI; Harris AL; Gatter KC
    Anticancer Res; 1998; 18(5B):3689-93. PubMed ID: 9854478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer.
    Giatromanolaki A; Bates GJ; Koukourakis MI; Sivridis E; Gatter KC; Harris AL; Banham AH
    Gynecol Oncol; 2008 Aug; 110(2):216-21. PubMed ID: 18533240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of basic fibroblastic growth factor and microvessel density in endometrial carcinoma].
    Bai X; Mi R
    Zhonghua Fu Chan Ke Za Zhi; 2000 Jun; 35(6):348-51. PubMed ID: 11776176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of angiogenesis, p-53 tissue protein expression and serum VEGF in patients with endometrial cancer.
    Mazurek A; Pierzyński P; Kuć P; Kopinski P; Terlikowski S; Niklińska W; Trojan J; Laudański T
    Neoplasma; 2004; 51(3):193-7. PubMed ID: 15254672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 protein overexpression in early stage endometrial cancer.
    Kohlberger P; Gitsch G; Loesch A; Tempfer C; Kaider A; Reinthaller A; Kainz C; Breitenecker G
    Gynecol Oncol; 1996 Aug; 62(2):213-7. PubMed ID: 8751552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma.
    Soeda S; Nakamura N; Ozeki T; Nishiyama H; Hojo H; Yamada H; Abe M; Sato A
    Gynecol Oncol; 2008 Apr; 109(1):122-8. PubMed ID: 18289648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.